{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:33:23Z","timestamp":1786649603994,"version":"build-2736575974"},"reference-count":113,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:p>\n                    Huntington's disease is a neurodegenerative disease caused by the expansion mutation of a cytosine-adenine-guanine triplet in the exon 1 of the\n                    <jats:italic toggle=\"yes\">HTT<\/jats:italic>\n                    gene which is responsible for the production of the huntingtin (Htt) protein. In physiological conditions, Htt is involved in many cellular processes such as cell signaling, transcriptional regulation, energy metabolism regulation, DNA maintenance, axonal trafficking, and antiapoptotic activity. When the genetic alteration is present, the production of a mutant version of Htt (mHtt) occurs, which is characterized by a plethora of pathogenic activities that, finally, lead to cell death. Among all the cells in which mHtt exerts its dangerous activity, the GABAergic Medium Spiny Neurons seem to be the most affected by the mHtt-induced excitotoxicity both in the cortex and in the striatum. However, as the neurodegeneration proceeds ahead the neuronal loss grows also in other brain areas such as the cerebellum, hypothalamus, thalamus, subthalamic nucleus, globus pallidus, and substantia nigra, determining the variety of symptoms that characterize Huntington's disease. From a clinical point of view, Huntington's disease is characterized by a wide spectrum of symptoms spanning from motor impairment to cognitive disorders and dementia. Huntington's disease shows a prevalence of around 3.92 cases every 100,000 worldwide and an incidence of 0.48 new cases every 100,000\/year. To date, there is no available cure for Huntington's disease. Several treatments have been developed so far, aiming to reduce the severity of one or more symptoms to slow down the inexorable decline caused by the disease. In this context, the search for reliable strategies to target the different aspects of Huntington's disease become of the utmost interest. In recent years, a variety of studies demonstrated the detrimental role of neuronal loss in Huntington's disease condition highlighting how the replacement of lost cells would be a reasonable strategy to overcome the neurodegeneration. In this view, numerous have been the attempts in several preclinical models of Huntington's disease to evaluate the feasibility of invasive and non-invasive approaches. Thus, the aim of this review is to offer an overview of the most appealing approaches spanning from stem cell-based cell therapy to extracellular vesicles such as exosomes in light of promoting neurogenesis, discussing the results obtained so far, their limits and the future perspectives regarding the neural regeneration in the context of Huntington's disease.\n                  <\/jats:p>","DOI":"10.4103\/1673-5374.390969","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T09:07:35Z","timestamp":1702544855000},"page":"1991-1997","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutic advances in neural regeneration for Huntington's disease"],"prefix":"10.4103","volume":"19","author":[{"given":"Francesco","family":"D'Egidio","sequence":"first","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-3218","authenticated-orcid":false,"given":"Vanessa","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Lombardozzi","sequence":"additional","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ammannito","sequence":"additional","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Cimini","sequence":"additional","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-840X","authenticated-orcid":false,"given":"Michele","family":"d'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"R1-20260525","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1176\/appi.neuropsych.20220033","article-title":"Frequency and pathophysiology of apathy in Huntington disease: a systematic review and meta-analysis","volume":"35","author":"Abdollah Zadegan","year":"2023","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R2-20260525","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"R3-20260525","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.3390\/ijms22084085","article-title":"Emerging roles of exosomes in Huntington's disease","volume":"22","author":"Ananbeh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R4-20260525","first-page":"e28484","article-title":"Huntington's disease: a clinical review","volume":"14","author":"Andhale","year":"2022","journal-title":"Cureus"},{"key":"R5-20260525","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/stem.3016","article-title":"Mesenchymal stem cells: from roots to boost","volume":"37","author":"Andrzejewska","year":"2019","journal-title":"Stem Cells"},{"key":"R6-20260525","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.3390\/cells9122663","article-title":"Stem cell-derived exosomes as therapeutic approach for neurodegenerative disorders: from biology to biotechnology","volume":"9","author":"Araldi","year":"2020","journal-title":"Cells"},{"key":"R7-20260525","article-title":"Clinical extension study for safety and efficacy evaluation of cellavita-HD administration in Huntington's patients","author":"Azidus","year":"2022"},{"key":"R8-20260525","article-title":"Dose-response evaluation of the cellavita HD product in patients with Huntington's disease","author":"Azidus","year":"2022"},{"key":"R9-20260525","article-title":"Safety evaluation of cellavita HD administered intravenously in participants with Huntington's disease","author":"Azidus","year":"2022"},{"key":"R10-20260525","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after neural transplantation","volume":"356","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Lancet"},{"key":"R11-20260525","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-L\u00e9vi","year":"2006","journal-title":"Lancet Neurol"},{"key":"R12-20260525","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/mds.28201","article-title":"Human fetal cell therapy in Huntington's disease: a randomized, multicenter, phase II trial","volume":"35","author":"Bachoud-L\u00e9vi","year":"2020","journal-title":"Mov Disord"},{"key":"R13-20260525","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/stem.3300","article-title":"Cell therapy in Huntington's disease: taking stock of past studies to move the field forward","volume":"39","author":"Bachoud-L\u00e9vi","year":"2021","journal-title":"Stem Cells"},{"key":"R14-20260525","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/NEN.0b013e3181ea167f","article-title":"Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease","volume":"69","author":"Benn","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"R15-20260525","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13311-011-0075-8","article-title":"Cellular therapy and induced neuronal replacement for Huntington's disease","volume":"8","author":"Benraiss","year":"2011","journal-title":"Neurotherapeutics"},{"key":"R16-20260525","doi-asserted-by":"crossref","first-page":"628010","DOI":"10.3389\/fncel.2021.628010","article-title":"D1R- and D2R-medium-sized spiny neurons diversity: insights into striatal vulnerability to Huntington's disease mutation","volume":"15","author":"Bergonzoni","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"R17-20260525","doi-asserted-by":"crossref","first-page":"891713","DOI":"10.3389\/fnins.2022.891713","article-title":"What is the relationship between hippocampal neurogenesis across different stages of the lifespan?","volume":"16","author":"Bond","year":"2022","journal-title":"Front Neurosci"},{"key":"R18-20260525","doi-asserted-by":"crossref","first-page":"e67436","DOI":"10.7554\/eLife.67436","article-title":"Single-cell analysis of the ventricular-subventricular zone reveals signatures of dorsal and ventral adult neurogenesis","volume":"10","author":"Cebrian-Silla","year":"2021","journal-title":"Elife"},{"key":"R19-20260525","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymthe.2019.09.003","article-title":"A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion","volume":"28","author":"Chen","year":"2020","journal-title":"Mol Ther"},{"key":"R20-20260525","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41536-019-0066-7","article-title":"Combination of stem cell and gene therapy ameliorates symptoms in Huntington's disease mice","volume":"4","author":"Cho","year":"2019","journal-title":"NPJ Regen Med"},{"key":"R21-20260525","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1172\/JCI31778","article-title":"Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease","volume":"117","author":"Cho","year":"2007","journal-title":"J Clin Invest"},{"key":"R22-20260525","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/ph16030436","article-title":"Engineered mesenchymal stem cells over-expressing BDNF protect the brain from traumatic brain injury-induced neuronal death, neurological deficits, and cognitive impairments","volume":"16","author":"Choi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"R23-20260525","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrn3484","article-title":"Emerging roles of astrocytes in neural circuit development","volume":"14","author":"Clarke","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"R24-20260525","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/stem.2747","article-title":"Concise review: the use of stem cells for understanding and treating Huntington's disease","volume":"36","author":"Connor","year":"2018","journal-title":"Stem Cells"},{"key":"R25-20260525","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.1532244100","article-title":"Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain","volume":"100","author":"Curtis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-20260525","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/antiox12030571","article-title":"Cell rearrangement and oxidant\/antioxidant imbalance in Huntington's disease","volume":"12","author":"D'Egidio","year":"2023","journal-title":"Antioxidants"},{"key":"R27-20260525","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hipo.23052","article-title":"Targeting hippocampal adult neurogenesis using transcription factors to reduce Alzheimer's disease-associated memory impairments","volume":"29","author":"Dard","year":"2019","journal-title":"Hippocampus"},{"key":"R28-20260525","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","article-title":"Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease","volume":"214","author":"Dey","year":"2010","journal-title":"Behav Brain Res"},{"key":"R29-20260525","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/mt.2016.126","article-title":"Exosome-mediated delivery of hydrophobically modified siRNA for Huntingtin mRNA silencing","volume":"24","author":"Didiot","year":"2016","journal-title":"Mol Ther"},{"key":"R30-20260525","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nn1144","article-title":"The glial identity of neural stem cells","volume":"6","author":"Doetsch","year":"2003","journal-title":"Nat Neurosci"},{"key":"R31-20260525","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1523\/JNEUROSCI.17-13-05046.1997","article-title":"Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain","volume":"17","author":"Doetsch","year":"1997","journal-title":"J Neurosci"},{"key":"R32-20260525","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0092-8674(00)80783-7","article-title":"Subventricular zone astrocytes are neural stem cells in the adult mammalian brain","volume":"97","author":"Doetsch","year":"1999","journal-title":"Cell"},{"key":"R33-20260525","doi-asserted-by":"crossref","first-page":"fcaa230","DOI":"10.1093\/braincomms\/fcaa230","article-title":"Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington's disease","volume":"3","author":"Drew","year":"2021","journal-title":"Brain Commun"},{"key":"R34-20260525","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol Dis"},{"key":"R35-20260525","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2014.01.044","article-title":"Neurogenesis in the striatum of the adult human brain","volume":"156","author":"Ernst","year":"2014","journal-title":"Cell"},{"key":"R36-20260525","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/1073858413504465","article-title":"Glial biology in learning and cognition","volume":"20","author":"Fields","year":"2014","journal-title":"Neuroscientist"},{"key":"R37-20260525","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology","volume":"97","author":"Freeman","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-20260525","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"R39-20260525","doi-asserted-by":"crossref","first-page":"e23837","DOI":"10.1371\/journal.pone.0023837","article-title":"Regulation of miR-146a by RelA\/NFkB and p53 in STHdh(Q111)\/Hdh(Q111) cells, a cell model of Huntington's disease","volume":"6","author":"Ghose","year":"2011","journal-title":"PLoS One"},{"key":"R40-20260525","first-page":"1","article-title":"Clinical features of Huntington's disease","author":"Ghosh","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"R41-20260525","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2011.06.040","article-title":"Neurogenesis in Huntington's disease: Can studying adult neurogenesis lead to the development of new therapeutic strategies?","author":"Gil-Mohapel","year":"2011","journal-title":"Brain Res"},{"key":"R42-20260525","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.tins.2003.09.011","article-title":"Glia as neural progenitor cells","volume":"26","author":"Goldman","year":"2003","journal-title":"Trends Neurosci"},{"key":"R43-20260525","doi-asserted-by":"crossref","first-page":"e0200626","DOI":"10.1371\/journal.pone.0200626","article-title":"Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+\/- mouse model of Huntington's disease","volume":"13","author":"Goodliffe","year":"2018","journal-title":"PLoS One"},{"key":"R44-20260525","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur J Neurosci"},{"key":"R45-20260525","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun Signal"},{"key":"R46-20260525","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"R47-20260525","doi-asserted-by":"crossref","first-page":"738442","DOI":"10.3389\/fnins.2021.738442","article-title":"The emerging role of neural cell-derived exosomes in intercellular communication in health and neurodegenerative diseases","volume":"15","author":"Huo","year":"2021","journal-title":"Front Neurosci"},{"key":"R48-20260525","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"R49-20260525","doi-asserted-by":"crossref","first-page":"18189","DOI":"10.1073\/pnas.0506375102","article-title":"FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease","volume":"102","author":"Jin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-20260525","doi-asserted-by":"crossref","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","article-title":"MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms","volume":"8","author":"Jovicic","year":"2013","journal-title":"PLoS One"},{"key":"R51-20260525","doi-asserted-by":"crossref","first-page":"576444","DOI":"10.3389\/fncel.2020.576444","article-title":"Beyond the hippocampus and the SVZ: adult neurogenesis throughout the brain","volume":"14","author":"Jurkowski","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R52-20260525","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"R53-20260525","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/NEN.0b013e3181e4f733","article-title":"Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-\u03b2 signaling in an animal model of Huntington disease","volume":"69","author":"Kandasamy","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"R54-20260525","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fncel.2018.00037","article-title":"Reactive neuroblastosis in Huntington's disease: a putative therapeutic target for striatal regeneration in the adult brain","volume":"12","author":"Kandasamy","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"R55-20260525","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","article-title":"Neural transplantation in Huntington disease: long-term grafts in two patients","volume":"68","author":"Keene","year":"2007","journal-title":"Neurology"},{"key":"R56-20260525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","article-title":"A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions","volume":"117","author":"Keene","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R57-20260525","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.102539","article-title":"Advances in cellular and cell-free therapy medicinal products for Huntington disease treatment","author":"Kerkis","year":"2022","journal-title":"From pathophysiology to treatment of Huntington's disease: IntechOpen"},{"key":"R58-20260525","doi-asserted-by":"crossref","first-page":"13672","DOI":"10.3390\/ijms222413672","article-title":"Therapeutic potential of mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles for the treatment of spinal cord injury","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R59-20260525","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2007.04.039","article-title":"Physical activity fails to rescue hippocampal neurogenesis deficits in the R6\/2 mouse model of Huntington's disease","author":"Kohl","year":"2007","journal-title":"Brain Res"},{"key":"R60-20260525","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exnr.1997.6685","article-title":"Safety of intrastriatal neurotransplantation for Huntington's disease patients","volume":"149","author":"Kopyov","year":"1998","journal-title":"Exp Neurol"},{"key":"R61-20260525","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1460-9568.2006.04715.x","article-title":"Neurogenesis in the R6\/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment","volume":"23","author":"Lazic","year":"2006","journal-title":"Eur J Neurosci"},{"key":"R62-20260525","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/ejn.13275","article-title":"Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's disease in vitro model","volume":"44","author":"Lee","year":"2016","journal-title":"Eur J Neurosci"},{"key":"R63-20260525","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14802\/jmd.16054","article-title":"Exosome-based delivery of miR-124 in a Huntington's disease model","volume":"10","author":"Lee","year":"2017","journal-title":"J Mov Disord"},{"key":"R64-20260525","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.neuron.2016.08.004","article-title":"In vivo reprogramming for CNS repair: regenerating neurons from endogenous glial cells","volume":"91","author":"Li","year":"2016","journal-title":"Neuron"},{"key":"R65-20260525","doi-asserted-by":"crossref","first-page":"9636897221149130","DOI":"10.1177\/09636897221149130","article-title":"VEGF-expressing mesenchymal stem cell therapy for safe and effective treatment of pain in Parkinson's disease","volume":"32","author":"Li","year":"2023","journal-title":"Cell Transplant"},{"key":"R66-20260525","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/aps.2017.178","article-title":"Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"R67-20260525","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2016.05.015","article-title":"Hippocampal adult neurogenesis: its regulation and potential role in spatial learning and memory","author":"Lieberwirth","year":"2016","journal-title":"Brain Res"},{"key":"R68-20260525","doi-asserted-by":"crossref","first-page":"e22924","DOI":"10.1371\/journal.pone.0022924","article-title":"Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"R69-20260525","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1126\/science.271.5251.978","article-title":"Chain migration of neuronal precursors","volume":"271","author":"Lois","year":"1996","journal-title":"Science (New York, NY)"},{"key":"R70-20260525","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.neuroscience.2011.09.010","article-title":"No change in progenitor cell proliferation in the hippocampus in Huntington's disease","volume":"199","author":"Low","year":"2011","journal-title":"Neuroscience"},{"key":"R71-20260525","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","article-title":"Prevalence and incidence of Huntington's disease: an updated systematic review and meta-analysis","volume":"37","author":"Medina","year":"2022","journal-title":"Mov Disord"},{"key":"R72-20260525","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuron.2011.05.001","article-title":"Adult neurogenesis in the mammalian brain: significant answers and significant questions","volume":"70","author":"Ming","year":"2011","journal-title":"Neuron"},{"key":"R73-20260525","doi-asserted-by":"crossref","first-page":"e143780","DOI":"10.1172\/JCI143780","article-title":"Overcoming innate immune barriers that impede AAV gene therapy vectors","volume":"131","author":"Muhuri","year":"2021","journal-title":"J Clin Invest"},{"key":"R74-20260525","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.stemcr.2015.03.006","article-title":"SOX2 reprograms resident astrocytes into neural progenitors in the adult brain","volume":"4","author":"Niu","year":"2015","journal-title":"Stem Cell Reports"},{"key":"R75-20260525","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fneur.2020.00148","article-title":"Therapeutic plasticity of neural stem cells","volume":"11","author":"Ottoboni","year":"2020","journal-title":"Front Neurol"},{"key":"R76-20260525","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","article-title":"Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in huntington's disease transgenic mice","volume":"141","author":"Pang","year":"2006","journal-title":"Neuroscience"},{"key":"R77-20260525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-3-17","article-title":"pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking","volume":"3","author":"Pardo","year":"2010","journal-title":"Mol Brain"},{"key":"R78-20260525","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41536-021-00198-0","article-title":"SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease","volume":"7","author":"Park","year":"2022","journal-title":"NPJ Regen Med"},{"key":"R79-20260525","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington's disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp Neurol"},{"key":"R80-20260525","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/096368979700600303","article-title":"Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations","volume":"6","author":"Philpott","year":"1997","journal-title":"Cell Transplant"},{"key":"R81-20260525","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41232-022-00193-y","article-title":"Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination","volume":"42","author":"Quan","year":"2022","journal-title":"Inflamm Regen"},{"key":"R82-20260525","doi-asserted-by":"crossref","first-page":"874387","DOI":"10.1155\/2012\/874387","article-title":"Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's disease","volume":"2012","author":"Ransome","year":"2012","journal-title":"Neural Plasticity"},{"key":"R83-20260525","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475","volume":"73","author":"Rosser","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R84-20260525","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/brain\/awac086","article-title":"Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder","volume":"145","author":"Rosser","year":"2022","journal-title":"Brain"},{"key":"R85-20260525","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","article-title":"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes","volume":"217","author":"Rossignol","year":"2011","journal-title":"Behav Brain Res"},{"key":"R86-20260525","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/stem.1508","article-title":"Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease","volume":"32","author":"Rossignol","year":"2014","journal-title":"Stem Cells"},{"key":"R87-20260525","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.nbd.2011.11.002","article-title":"Modification of Mecp2 dosage alters axonal transport through the Huntingtin\/Hap1 pathway","volume":"45","author":"Roux","year":"2012","journal-title":"Neurobiol Dis"},{"key":"R88-20260525","doi-asserted-by":"crossref","first-page":"105228","DOI":"10.1016\/j.parkreldis.2022.11.020","article-title":"Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients","volume":"106","author":"Ruiz-Idiago","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"R89-20260525","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1073\/pnas.1902513116","article-title":"Exosomes regulate neurogenesis and circuit assembly","volume":"116","author":"Sharma","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R90-20260525","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2010.09.012","article-title":"Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease","volume":"41","author":"Simpson","year":"2011","journal-title":"Neurobiol Dis"},{"key":"R91-20260525","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/ijms22042153","article-title":"Regenerative stem cell therapy for neurodegenerative diseases: an overview","volume":"22","author":"Sivandzade","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R92-20260525","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.stemcr.2020.01.015","article-title":"Aberrant development corrected in adult-onset Huntington's disease iPSC-derived neuronal cultures via WNT signaling modulation","volume":"14","author":"Smith-Geater","year":"2020","journal-title":"Stem Cell Reports"},{"key":"R93-20260525","doi-asserted-by":"crossref","first-page":"e9347","DOI":"10.1371\/journal.pone.0009347","article-title":"Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease","volume":"5","author":"Snyder","year":"2010","journal-title":"PLoS One"},{"key":"R94-20260525","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism","volume":"24","author":"Spires","year":"2004","journal-title":"J Neurosci"},{"key":"R95-20260525","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fncel.2020.00107","article-title":"Regeneration through in vivo cell fate reprogramming for neural repair","volume":"14","author":"Tai","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R96-20260525","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4103\/1673-5374.353482","article-title":"In vivo astrocyte-to-neuron reprogramming for central nervous system regeneration: a narrative review","volume":"18","author":"Talifu","year":"2023","journal-title":"Neural Regen Res"},{"key":"R97-20260525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neubiorev.2017.02.017","article-title":"Regenerative medicine in Huntington's disease: Strengths and weaknesses of preclinical studies","volume":"77","author":"Tartaglione","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"R98-20260525","doi-asserted-by":"crossref","first-page":"345","DOI":"10.21037\/tau-20-1072","article-title":"Effect of high-BDNF microenvironment stem cells therapy on neurogenic bladder model in rats","volume":"10","author":"Tian","year":"2021","journal-title":"Transl Androl Urol"},{"key":"R99-20260525","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/17425247.2019.1645116","article-title":"Drug-like delivery methods of stem cells as biologics for stroke","volume":"16","author":"Tuazon","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"R100-20260525","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-030-31206-0_4","article-title":"Neural stem cells","author":"Tuazon","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"R101-20260525","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12929-021-00755-1","article-title":"The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease","volume":"28","author":"Tung","year":"2021","journal-title":"J Biomed Sci"},{"key":"R102-20260525","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington's in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"R103-20260525","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12035-021-02603-7","article-title":"Insights of extracellular vesicles of mesenchymal stem cells: a prospective cell-free regenerative medicine for neurodegenerative disorders","volume":"59","author":"Vatsa","year":"2022","journal-title":"Mol Neurobiol"},{"key":"R104-20260525","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol Ther"},{"key":"R105-20260525","doi-asserted-by":"crossref","first-page":"110661","DOI":"10.1016\/j.brainresbull.2023.110661","article-title":"Strategies and mechanisms of neuronal reprogramming","volume":"199","author":"Wan","year":"2023","journal-title":"Brain Res Bull"},{"key":"R106-20260525","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.050930","article-title":"Factors associated with HD CAG repeat instability in Huntington disease","volume":"44","author":"Wheeler","year":"2007","journal-title":"J Med Genet."},{"key":"R107-20260525","first-page":"A88","article-title":"I02 Systemic injection of exosomal sirna significantly reduced huntingtin expression in transgenic mice of huntington's disease","volume":"89","author":"Wu","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R108-20260525","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-020-14855-3","article-title":"Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"R109-20260525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40035-022-00330-0","article-title":"Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases","volume":"11","author":"Xia","year":"2022","journal-title":"Transl Neurodegener"},{"key":"R110-20260525","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-022-00553-9","article-title":"Combination therapy using GDNF and cell transplant in Parkinson's disease","volume":"17","author":"Xiao","year":"2022","journal-title":"Mol Neurodegener"},{"key":"R111-20260525","doi-asserted-by":"crossref","first-page":"558204","DOI":"10.3389\/fnins.2020.558204","article-title":"Neural transplants from human induced pluripotent stem cells rescue the pathology and behavioral defects in a rodent model of Huntington's disease","volume":"14","author":"Yoon","year":"2020","journal-title":"Front Neurosci"},{"key":"R112-20260525","doi-asserted-by":"crossref","DOI":"10.1038\/s44222-023-00064-2","article-title":"Stem cell-derived exosome versus stem cell therapy","author":"Zhang","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"R113-20260525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.390969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:55:51Z","timestamp":1786647351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.390969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.390969","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"2023-07-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}